| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| HTFL | Heartflow, Inc. | Common Stock, $0.001 par value per share | 14.9% | $419M | 12.4M | BCLS Fund III Investments, LP | Sep 30, 2025 | ||
| NAMS | NewAmsterdam Pharma Company N.V. | Ordinary Shares, nominal value Euro 0.12 per share | 9.99% | $325M | 11.4M | BCLS Fund III Investments, LP | Nov 5, 2025 | ||
| CDTX | CIDARA THERAPEUTICS, INC. | Common Stock, $0.0001 par value per share | 9.99% | $289M | $49.8M | 3.02M | +20.8% | BCLS Fund III Investments, LP | Sep 30, 2025 |
| DNTH | DIANTHUS THERAPEUTICS, INC. | Common Stock, $0.001 par value per share | 3.1% | $51.8M | -$45.9M | 1.32M | -47% | BCLS Fund III Investments, LP | Sep 30, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|